**Core Concept**
Reagenic hypersensitivity, also known as type I hypersensitivity, is an immediate allergic reaction mediated by the immune system. This reaction occurs in response to the release of histamine and other chemical mediators from mast cells and basophils.

**Why the Correct Answer is Right**
The correct answer is IgE antibodies, which are responsible for triggering the release of histamine and other chemical mediators from mast cells and basophils. IgE antibodies bind to the surface of mast cells and basophils, and when they encounter their specific antigen, they cross-link, leading to the release of histamine and other chemical mediators. This leads to increased vascular permeability, smooth muscle contraction, and other symptoms associated with anaphylaxis. The IgE pathway is a key component of the allergic response, and it is responsible for the development of allergic diseases such as asthma, rhinitis, and atopic dermatitis.

**Why Each Wrong Option is Incorrect**
**Option A:** IgG antibodies are involved in type II and type III hypersensitivity reactions, not type I hypersensitivity.
**Option B:** IgA antibodies are primarily involved in mucosal immunity and are not responsible for reagenic hypersensitivity.
**Option C:** IgM antibodies are also involved in type II and type III hypersensitivity reactions, but not in type I hypersensitivity.

**Clinical Pearl / High-Yield Fact**
It's essential to remember that IgE antibodies are responsible for triggering the allergic response, and that type I hypersensitivity is an immediate reaction, typically occurring within minutes of exposure to the allergen.

**Correct Answer: D. IgE antibodies.